History
Mission and Vision About History Company News EHS Technology and Patents Contact us
1999, Taxus plantation
……
2001, company established
2007, GMP approved
2009, company name change to current
2011, sales volume more than RMB100million
2012, passed GMP re-inspection
2014, IPO, received production license of Letrozole,Gefitinib and Erlotinib
2015, received Docetaxel GMP, received BE license of Imatinib,Erlotinib(API and tablet), passed US-FDA GMP inspection.
2016, received Paclitaxel GMP, received BE license of Letrzole(API and tablet)

……
 
分享:

南方制药官方微信

南方制药官方微信